Deutsche Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $152M | Sell |
|
|||||
|
2023
Q1 | $136M | Buy |
|
|||||
|
2022
Q4 | $56.7M | Buy |
|
|||||
|
2022
Q3 | $25.6M | Buy |
|
|||||
|
2022
Q2 | $19.2M | Sell |
|
|||||
|
2022
Q1 | $20.7M | Sell |
|
|||||
|
2021
Q4 | $17.1M | Buy |
|
|||||
|
2021
Q3 | $65.3M | Buy |
|
|||||
|
2021
Q2 | $91.3M | Buy |
|
|||||
|
2021
Q1 | $60.6M | Buy |
|
|||||
|
2020
Q4 | $41.4M | Buy |
|
|||||
|
2020
Q3 | $31.3M | Buy |
|
|||||
|
2020
Q2 | $46.2M | Buy |
|
|||||
|
2020
Q1 | $37.7M | Sell |
|
|||||
|
2019
Q4 | $59.6M | Buy |
|
|||||
|
2019
Q3 | $5.56M | Buy |
|
|||||
|
2019
Q2 | $5.75M | Sell |
|
|||||
|
2019
Q1 | $6.3M | Sell |
|
|||||
|
2018
Q4 | $9.61M | Buy |
|
|||||
|
2018
Q3 | $10.1M | Buy |
|
|||||
|
2018
Q2 | $1.33M | Buy |
|
|||||
|
2018
Q1 | $374K | Sell |
|
|||||
|
2017
Q4 | $717K | Buy |
|
|||||
|
2017
Q3 | $318K | Sell |
|
|||||
|
2017
Q2 | $1.1M | Buy |
|
|||||
|
2017
Q1 | $152K | Buy |
|
|||||
|
2016
Q4 | $70K | Buy |
|
|||||
|
2016
Q3 | $24K | Sell |
|
|||||
|
2016
Q2 | $118K | Buy |
|